CARE Hospitals, Visakhapatnam ( Maharanipeta )

Details Doctors
Medical Suppliers In Andhra Pradesh

Name :

CARE Hospitals Visakhapatnam Maharanipeta

Address  :

17-1-1,
KGH Road Maharanipeta

Town  :

Visakhapatnam

State  :

Andhra Pradesh

Country  :

INDIA

Post Code:

530002

Phone  :

+91-0891-3067000

Fax  :

+91-891-2555799

Web URL  :

Available

Email  :

info@carehospitals.com
CARE Hospitals Visakhapatnam Maharanipeta

Doctors Of CARE Hospitals, Visakhapatnam ( Maharanipeta )
Physician
Qualification
Availability
B Padmaja
B Padmaja
DNB, MCROG
Resident
B Satheesh Babu
B Satheesh Babu
Ms(Gen surgery)
Resident
C S Srinivas
C S Srinivas
MD (Paed.)
Resident
C V Rao
C V Rao
MD, DM (Cardio.)
Resident
D Prabhakar
D Prabhakar
MD, DM (Nephrology)
Resident
D Sunitha
D Sunitha
MD (General Medicine)
Resident
G S R Murty
MD, DM (Cardiology)
Resident
G Sailaja Satyanarayana
G Sailaja Satyanarayana
MD
Resident
G Satyanarayana
G Satyanarayana
MD, DM (Gastroenterology)
Resident
I K Raju
Resident
K Sandhya Rani
MD(Obgy)
Resident
Kalyan Chakravarthy Jallu
Kalyan Chakravarthy Jallu
MBBS, MS (Orthopedics)
Resident
Karunakar Padhy
Karunakar Padhy
MS, Mch (CTVS)
Resident
Leena Maitri
MSc (Nutrition)
Resident
N V S Mohan
M.Ch (Neurosurgery), DNB ( Neurosurgery)
Resident
Nageswara Rao B
MD
Resident
Nageswara Rao Boddapati
MBBS, DNB (General Medicine)
Resident
P K Chakrabarthi
P K Chakrabarthi
MBBS, Diploma in Internal Medicine (USA)
Resident
P Raju Naidu Pothulu
MBBS, MS (Ortho), Fellowship in Joint Replacement
Resident
P V V N M Kumar
P V V N M Kumar
MD, DM (Cardio.)
Resident
NEWS
Early detection can prevent most cancers from turning deadly report

Most cancers that kill Indians oral cavity breast cervical are preventable if detected at an early stage said doctors who conducted the study on cancerrelated deaths in India The study was published in The Lancet on Wednesday In 2010 23 of cancer deaths among men were because of oral cavity cancers Among women 17 of the deaths were because of ... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More